Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)

v3.21.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
 1 Months Ended 12 Months Ended
Apr. 08, 2019
Apr. 30, 2019
Dec. 31, 2020
Dec. 31, 2019
Initial Public Offering        
Income available outside of the Trust Account     $ 850,000  
Working deficit     836,000  
Note payable to related party     250,000  
Advance from related party     2,000  
Net proceeds not held in Trust Account     2,000,000  
Maximum working capital loans which may be converted to warrants     $ 1,500,000  
Exercise price of warrant (in dollars per share)     $ 1.00  
Outstanding borrowings under working capital loans     $ 0  
Federal depository insurance coverage     $ 250,000  
Shares subject to possible redemption     27,829,229 27,942,373
Gain on marketable securities, dividends and interest held in Trust Account     $ 1,261,249 $ 4,554,158
Net income     (1,131,437) 4,226,759
Loss from operations     $ (2,392,686) $ (327,399)
Basic and diluted weighted average shares outstanding of Founder Shares     7,187,500.00 7,187,500.00
Unrecognized tax benefits     $ 0 $ 0
Accrual for interest and penalties     0 $ 0
IPO        
Initial Public Offering        
Exercise price of warrant (in dollars per share) $ 11.50      
Number of shares issued 28,750,000 28,750,000    
Private Placement        
Initial Public Offering        
Purchase of ordinary shares     22,125,000  
Ordinary Shares | IPO        
Initial Public Offering        
Number of shares issued       28,750,000
Sponsor        
Initial Public Offering        
Annual limit of amount released to the Company to fund working capital requirements     $ 25,000